Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 de » 2 d (Expand Search), _ de (Expand Search), i de (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 de » 2 d (Expand Search), _ de (Expand Search), i de (Expand Search)
-
5681
-
5682
-
5683
-
5684
-
5685
-
5686
-
5687
Natural Products Discovered in a High-Throughput Screen Identified as Inhibitors of RGS17 and as Cytostatic and Cytotoxic Agents for Lung and Prostate Cancer Cell Lines
Published 2017“…Using high-throughput screening, a chemical library containing natural products was interrogated for inhibition of the RGS17–Gα<sub>o</sub> interaction. …”
-
5688
Introducing the 4‑Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates
Published 2016“…Osmium(II) cyclometalates exhibited higher antiproliferative activities than their ruthenium(II) counterparts. The IC<sub>50</sub> values within each metal series decreased with increasing lipophilicity, which was attributed to higher cellular accumulation. …”
-
5689
-
5690
-
5691
-
5692
-
5693
-
5694
-
5695
-
5696
-
5697
Comparison of Rho A and ROCK II Expression in Lung Tissue among the Groups.
Published 2016“…<p>A western blot analysis revealed that treatment with atorvastatin resulted in significant decreases in the levels of both RhoA and ROCK II in the AOB<sub>63</sub>/ATOR<sub>63</sub> group, but a decrease in only RhoA was detected in the AOB<sub>63</sub>/ATOR<sub>50-63</sub> group. …”
-
5698
-
5699
Data_Sheet_1_A de novo GRIN1 Variant Associated With Myoclonus and Developmental Delay: From Molecular Mechanism to Rescue Pharmacology.pdf
Published 2021“…NMDARs that contained the P532H within the glycine-binding domain of GluN1 with either the GluN2A or GluN2B subunits were evaluated for changes in their pharmacological and biophysical properties, which surprisingly revealed only modest changes in glycine potency but a significant decrease in glutamate potency, an increase in sensitivity to endogenous zinc inhibition, a decrease in response to maximally effective concentrations of agonists, a shortened synaptic-like response time course, a decreased channel open probability, and a reduced receptor cell surface expression. …”
-
5700